Tod Steinfeld

Molecular mechanisms and physiological importance of circadian rhythms

Trends in GPCR drug discovery: new agents, targets and indications

Molecular Dynamics Simulation for All

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update

Emerging paradigms in GPCR allostery: implications for drug discovery

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review

Teaching old receptors new tricks: biasing seven-transmembrane receptors

Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act?

International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands

Click Chemistry for Drug Development and Diverse Chemical–Biology Applications

Hybrid Ortho/Allosteric Ligands for the Adenosine A₁Receptor

The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors

Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor

Microglial M1/M2 polarization and metabolic states

Sulfur(VI) Fluoride Exchange (SuFEx)-Enabled High-Throughput Medicinal Chemistry

Bivalent Dopamine D₂Receptor Ligands: Synthesis and Binding Properties

A Novel Multivalent Ligand That Bridges the Allosteric and Orthosteric Binding Sites of the M2 Muscarinic Receptor

Carbazole-containing sulfonamides and sulfamides: Discovery of cryptochrome modulators as antidiabetic agents